A detailed history of Sterling Capital Management LLC transactions in Beam Therapeutics Inc. stock. As of the latest transaction made, Sterling Capital Management LLC holds 2,409 shares of BEAM stock, worth $58,370. This represents 0.0% of its overall portfolio holdings.

Number of Shares
2,409
Previous 263 815.97%
Holding current value
$58,370
Previous $6.44 Million 827.11%
% of portfolio
0.0%
Previous 0.0%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2024

Feb 13, 2025

BUY
$21.55 - $30.35 $46,246 - $65,131
2,146 Added 815.97%
2,409 $59.7 Million
Q3 2024

Nov 12, 2024

BUY
$22.57 - $33.14 $5,935 - $8,715
263 New
263 $6.44 Million

Others Institutions Holding BEAM

About Beam Therapeutics Inc.


  • Ticker BEAM
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 70,354,600
  • Market Cap $1.7B
  • Description
  • Beam Therapeutics Inc., a biotechnology company, develops precision genetic medicines for patients suffering from serious diseases in the United States. The company is developing BEAM-101 for the treatment of sickle cell disease and beta thalassemia; BEAM-102 for the treatment of sickle cell disease; and BEAM-201, an allogeneic chimeric antigen ...
More about BEAM
Track This Portfolio

Track Sterling Capital Management LLC Portfolio

Follow Sterling Capital Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Sterling Capital Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Sterling Capital Management LLC with notifications on news.